Dexamethasone distribution characteristic following controllable continuous sub-tenon drug delivery in rabbit.

Drug Delivery
Xuetao HuangDing Lin

Abstract

Drug delivery systems are required to be safe, minimally invasive and effectively delivery drug to the target tissues. But delivery drugs to the eye has not yet satisfied this need. Here, we focused on examining the distribution of dexamethasone (DEX) in ocular and plasmic samples following controllable continuous sub-Tenon drug delivery (CCSDD) of dexamethasone disodium phosphate (DEXP) in rabbit, and to compare that with two traditional routes: subconjunctival injection and intravenous injection. The DEX concentration was analyzed by Shimadzu LC-MS 2010 system. In CCSDD group, during observed 24 h, the mean DEX level in collected samples from highest to lowest following in order: sclera, cornea, retina/choroid, iris, plasma, aqueous humor, lens and vitreous body. In ocular solid tissue, the DEX level in posterior segment is higher than in anatomic corresponding anterior segment, but it is opposite in ocular fluid tissue. High levels of DEX were maintained at 12 h in the ocular tissue immediately after the administration. Even at 24 h, the mean DEX concentration was 31.72 ng/ml and 22.40 ng/ml in aqueous and vitreous, respectively. In CCSDD group, the ocular DEX exposure (AUC0-24) is much higher and plasma exposure is much les...Continue Reading

References

Aug 24, 1999·American Journal of Ophthalmology·O WeijtensJ C van Meurs
Oct 24, 2001·Advanced Drug Delivery Reviews·D H Geroski, H F Edelhauser
Sep 3, 2002·Survey of Ophthalmology·David M Maurice
Oct 20, 2004·Retina·Rama D JagerEmmett T Cunningham
Nov 22, 2005·Expert Opinion on Drug Delivery·Swita RaghavaUday B Kompella
Apr 17, 2007·Current Opinion in Ophthalmology·Jason Hsu
Apr 27, 2007·Investigative Ophthalmology & Visual Science·Deepta GhateHenry F Edelhauser
Feb 16, 2008·Drug Discovery Today·Eva M Del Amo, Arto Urtti
Aug 13, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Deniz DalkaraJohn G Flannery
Sep 14, 2010·Journal of Controlled Release : Official Journal of the Controlled Release Society·Veli-Pekka RantaArto Urtti
Dec 21, 2010·Drug Discovery Today·Thilini Rasika ThrimawithanaRaid Ghassan Alany
Feb 25, 2011·Drug Metabolism and Disposition : the Biological Fate of Chemicals·Ashish ThakurUday B Kompella
Mar 15, 2011·Therapeutic Delivery·Uday B KompellaVincent H L Lee
Jun 28, 2011·Ophthalmology·Chirag P ShahUNKNOWN Post-Injection Endophthalmitis (PIE) Study Team
Apr 10, 2012·European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences·Silvia PescinaSara Nicoli
May 24, 2013·JAMA Ophthalmology·Stephen J KimPaul Sternberg
Jun 4, 2014·Drug Delivery·Javed AliAsgar Ali
Jul 18, 2015·Journal of Controlled Release : Official Journal of the Controlled Release Society·Terry G CourseyGhanashyam Acharya
Jul 23, 2015·Annals of the New York Academy of Sciences·Scott M Whitcup, Michael R Robinson
Aug 21, 2015·Drug Delivery·Nurul Alimah Abdul NasirNafeeza Mohd Ismail
Dec 17, 2015·Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics·Venkata Kashyap Yellepeddi, Srinath Palakurthi
Jun 14, 2016·Expert Opinion on Drug Delivery·Luigi BattagliaMaria Angeles Solinis
Jul 21, 2016·Ocular Immunology and Inflammation·Dominika PohlmannUwe Pleyer
Aug 4, 2016·Expert Opinion on Drug Delivery·Raghu Raj Thakur SinghRyan F Donnelly
Aug 28, 2016·Drugs & Aging·Beatriz AbadiaLuis Pablo

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.